Showing results (221-230 of 359) with videos related to
Sort By:
Pageof 36
Blood Advances|April 19, 2022
Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphomaDiego Villa, Eva Hoster, Olivier Hermine, et al.Virchows Archiv : an International Journal of Pathology|January 25, 2020
Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11Giorgio A Croci, Eva Hoster, Sílvia Beà, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2023
CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase InhibitionAlan Cooper, Sravya Tumuluru, Kyle Kissick, et al.Blood Neoplasia|June 8, 2026
A phase 1 study of R-GDP-venetoclax before autologous transplant in relapsed/refractory large B-cell lymphoma (CCTG LY.18)Sarit Assouline, Anca Prica, Diego Villa, et al.Blood|September 2, 2025
The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell LymphomaDylan James Tatterton, Maddy L Newby, Joel D Allen, et al.Blood|September 6, 2012
Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trialKing L Tan, David W Scott, Fangxin Hong, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 17, 2013
Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopesDaniel J Hui, Etiena Basner-Tschakarjan, Yifeng Chen, et al.Leukemia|August 13, 2022
Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trialCiara L Freeman, Prasath Pararajalingam, Ling Jin, et al.Plos One|April 21, 2016
Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect CorrectionAline Talhouk, Stefan Kommoss, Robertson Mackenzie, et al.American Journal of Clinical Pathology|April 24, 2012
B cells with high side scatter parameter by flow cytometry correlate with inferior survival in diffuse large B-cell lymphomaAli Bashashati, Nathalie A Johnson, Alireza Hadj Khodabakhshi, et al.Pageof 36